Abstract
For testing bacterial susceptibility to PD131628, a 5-μg disk and the following tentative interpretative criteria may be used: ≥19 mm for susceptible (MIC, ≤1.0 μg/ml), 16 to 18 mm for intermediate (MIC, 2.0 μg/ml), and ≤15 mm for resistant (MIC, ≥4.0 μg/ml). For standard quality control strains, the following limits are proposed: for Escherichia coli ATCC 25922, zones of 31 to 41 mm or a MIC of 0.002 to 0.016 μg/ml; for Pseudomonas aeruginosa ATCC 27853, zones of 26 to 34 mm or a MIC of 0.12 to 0.5 μg/ml; for Staphylococcus aureus ATCC 25923, zones of 27 to 33 mm; for Staphylococcus aureus ATCC 29213, a MIC of 0.03 to 0.12 μg/ml; and for Enterococcus faecalis ATCC 29212, a MIC of 0.12 to 0.5 μg/ml.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 235-238 |
| Number of pages | 4 |
| Journal | Journal of Clinical Microbiology |
| Volume | 33 |
| Issue number | 1 |
| State | Published - 1995 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Microbiology (medical)
- Microbiology
Cite this
Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628. / Barry, A. L.; Fuchs, P. C.; Allen, S. D.; Tenover, F. C.; Jorgensen, J. H.; Reller, L. B.
In: Journal of Clinical Microbiology, Vol. 33, No. 1, 1995, p. 235-238.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Interpretive criteria and quality control parameters for testing bacterial susceptibility to the fluoroquinolone PD131628
AU - Barry, A. L.
AU - Fuchs, P. C.
AU - Allen, S. D.
AU - Tenover, F. C.
AU - Jorgensen, J. H.
AU - Reller, L. B.
PY - 1995
Y1 - 1995
N2 - For testing bacterial susceptibility to PD131628, a 5-μg disk and the following tentative interpretative criteria may be used: ≥19 mm for susceptible (MIC, ≤1.0 μg/ml), 16 to 18 mm for intermediate (MIC, 2.0 μg/ml), and ≤15 mm for resistant (MIC, ≥4.0 μg/ml). For standard quality control strains, the following limits are proposed: for Escherichia coli ATCC 25922, zones of 31 to 41 mm or a MIC of 0.002 to 0.016 μg/ml; for Pseudomonas aeruginosa ATCC 27853, zones of 26 to 34 mm or a MIC of 0.12 to 0.5 μg/ml; for Staphylococcus aureus ATCC 25923, zones of 27 to 33 mm; for Staphylococcus aureus ATCC 29213, a MIC of 0.03 to 0.12 μg/ml; and for Enterococcus faecalis ATCC 29212, a MIC of 0.12 to 0.5 μg/ml.
AB - For testing bacterial susceptibility to PD131628, a 5-μg disk and the following tentative interpretative criteria may be used: ≥19 mm for susceptible (MIC, ≤1.0 μg/ml), 16 to 18 mm for intermediate (MIC, 2.0 μg/ml), and ≤15 mm for resistant (MIC, ≥4.0 μg/ml). For standard quality control strains, the following limits are proposed: for Escherichia coli ATCC 25922, zones of 31 to 41 mm or a MIC of 0.002 to 0.016 μg/ml; for Pseudomonas aeruginosa ATCC 27853, zones of 26 to 34 mm or a MIC of 0.12 to 0.5 μg/ml; for Staphylococcus aureus ATCC 25923, zones of 27 to 33 mm; for Staphylococcus aureus ATCC 29213, a MIC of 0.03 to 0.12 μg/ml; and for Enterococcus faecalis ATCC 29212, a MIC of 0.12 to 0.5 μg/ml.
UR - http://www.scopus.com/inward/record.url?scp=0028938536&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028938536&partnerID=8YFLogxK
M3 - Article
C2 - 7699050
AN - SCOPUS:0028938536
VL - 33
SP - 235
EP - 238
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
SN - 0095-1137
IS - 1
ER -